Healthcare technology firm Semler Scientific has reached a tentative settlement agreement with the U.S. Department of Justice (DOJ), disclosing in a Tuesday filing that it was prepared to pay a $29.75 million fine in order to settle all claims tied to potential violations of a federal anti-fraud law related to its marketing of QuantaFlo, its flagship product.
Last month, Semler Scientific disclosed that it had received a civil investigative demand, or CID — essentially, a subpoena from a federal agency that typically precedes a lawsuit — from the DOJ back in 2017. In a filing with the U.S. Securities and Exchange Commission (SEC) Semler Scientific said it had complied with several subsequent subpoenas over the following years and began initial settlement discussions with the DOJ in February.
The investigation into Semler Scientific’s marketing of QuantaFlo is unrelated to its bitcoin holdings.
coindesk.com